| Just Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Writing and Speaking > Article Marketing > Article Marketing - When Do You Need to Give Journalistic Credit? |
|
Just Answers - Article Marketing - When Do You Need to Give Journalistic Credit?
Should you give credit when you are using information learned in other p According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product laces online or offline, or should you avoid making references? There's ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in no reason to avoid it...And any time that you quote anything, or any tim lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. that you use a statistic that comes from a specific website -- any of t here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe at stuff, really should be cited. Now most of the time, these internet a d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ticles, or the content that people are writing, to upload for web-conten ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc , or to drive traffic, are talking about information that is, you know, easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi eadily available. If it’s common knowledge that anybody that's perhaps nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically n the industry -- obviously, if somebody writes an article about, for ex and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ mple, dog-training -- if all of the information in there is pretty commo ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi knowledge to anybody that does dog-training, then none of that, needs t ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a o be cited at all. It's just common knowledge. And there's probably a b dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod tter journalistic word for that.. But anything that's common knowledge r cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ally doesn't need to be cited. And, I'd say, ninety-five percent of all tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen he articles that people write to drive traffic are usually some kind of t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ommon-knowledge. But again, if you use any kind of statistic that comes ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust rom a website, you really need to cite where that came from. But the bo y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products tom line is, if you quote something, of if it is not common knowledge, t . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de en your really need to cite the source of the information. And obviousl elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip anytime you quote anything, you need to use quotes, and cite the source tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:When Is The Best Time TO Take Your Company Public? Website Sitemaps - Google - Yahoo & MSN Do You Have a Business Credit Card?
|